More on LENZ

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-101.9% Growth)
- Ratings (8.6 Score)

Upcoming Events

- Earnings (8/19/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

LENZ Therapeutics, Inc. (NQ:LENZ)
Delayed: 5.18 +0.30 (6.15%)
Prev. Close $4.88  
Open$4.88 
52 Wk High$ 
52 Wk Low$ 
Day High$5.20 
Day Low$4.88 
P/E N/A  
EPS$ 
Volume1,116,591 

Friends, Peers and Foes (?): ABOS, CLYM, SLDB VERV (more...)

Jul 7, 2026 07:04 AM H.C. Wainwright Reiterates Buy Rating on LENZ Therapeutics Inc (LENZ)
Jul 2, 2026 05:01 PM Form 8-K LENZ Therapeutics, Inc. For: Jun 30
Jun 26, 2026 04:54 PM Form SCHEDULE 13G LENZ Therapeutics, Inc. Filed by: MILLENNIUM MANAGEMENT LLC
Jun 24, 2026 08:32 AM LENZ Therapeutics licenses VIZZ eye drop to Arrotex for Australia, NZ
Jun 24, 2026 08:30 AM LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
Jun 15, 2026 08:22 PM Form 4 LENZ Therapeutics, Inc. For: Jun 15 Filed by: RA Capital Healthcare Fund LP
Jun 15, 2026 08:18 PM Form 4 LENZ Therapeutics, Inc. For: Jun 15 Filed by: George Jeffrey P.
Jun 15, 2026 08:18 PM Form 4 LENZ Therapeutics, Inc. For: Jun 15 Filed by: Drapkin Kimberlee C
Jun 15, 2026 08:18 PM Form 4 LENZ Therapeutics, Inc. For: Jun 15 Filed by: Guerard Frederic
Jun 15, 2026 08:18 PM Form 4 LENZ Therapeutics, Inc. For: Jun 15 Filed by: Scheiner Zachary
View All Articles

Entities mentioned with LENZ

View All Entities